Genprex, Inc. Cash and Cash Equivalents
Genprex, Inc. (GNPX) had Cash and Cash Equivalents of $15.15 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $15.15M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $18.05M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $7.83M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $1.10M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $15.15M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $18.05M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $7.83M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $1.10M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.35M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $3.47M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.60M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $1.49M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $2.46M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $8.22M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $6.74M 10-K · filed 2025-04-01 | |
| 2023-09-30 | $11.71M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $9.96M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $18.08M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $20.95M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $25.52M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $30.05M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $34.56M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $38.63M 10-Q · filed 2022-11-14 | |
| 2021-09-30 | $42.02M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $44.24M 10-Q · filed 2021-08-13 | |
| 2020-12-31 | $27.32M 10-Q · filed 2021-11-15 | |
| 2018-09-30 | $10.31M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $12.00M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $24.48K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $161.25K 10-Q · filed 2018-11-14 | |
| 2017-09-30 | $373.95K 10-Q · filed 2018-11-14 | $373.94K 10-Q · filed 2017-12-05 |
| 2017-06-30 | $467.94K 10-Q · filed 2018-08-14 | |
| 2017-03-31 | $930.01K 10-Q · filed 2018-05-15 | |
| 2016-12-31 | $1.60M 10-Q · filed 2018-11-14 | |
| 2016-09-30 | $968.58K 10-Q · filed 2017-12-05 | |
| 2015-12-31 | $234.22K 10-K · filed 2018-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |